Literature DB >> 33765944

Improved detection of microbiological pathogens: role of partner and non-governmental organizations.

Michael Owusu1,2, Bernard Nkrumah3, Godfred Acheampong4, Ebenezer Kofi Mensah5, Abass Abdul-Karim Komei6, Festus Kofi Sroda7, Sambian David4, Shannon Emery8, Lucy Maryogo Robinson8, Kwame Asante8, David Opare9.   

Abstract

BACKGROUND: Proper detection of disease-causing organisms is very critical in controlling the course of outbreaks and avoiding large-scale epidemics. Nonetheless, availability of resources to address these gaps have been difficult due to limited funding. This report sought to highlight the importance of in-country partners and non-governmental organizations in improving detection of microbiological organisms in Ghanaian Public Health Laboratories (PHLs). METHODS/CONTEXT: This study was conducted between June, 2018 to August, 2019. U. S CDC engaged the Centre for Health Systems Strengthening (CfHSS) through the Association of Public Health Laboratories to design and implement strategies for strengthening three PHLs in Ghana. An assessment of the three PHLs was done using the WHO/CDS/CSR/ISR/2001.2 assessment tool. Based on findings from the assessments, partner organizations (CfHSS/APHL/CDC) serviced and procured microbiological equipment, laboratory reagents and logistics. CfHSS provided in-house mentoring and consultants to assist with capacity building in detection of epidemic-prone infectious pathogens by performing microbiological cultures and antimicrobial susceptibility tests.
RESULTS: A total of 3902 samples were tested: blood (1107), urine (1742), stool (249) and cerebrospinal fluid (CSF) (804). All-inclusive, 593 pathogenic bacteria were isolated from blood cultures (70; 11.8%); urine cultures (356; 60%); stool cultures (19; 3.2%) and from CSF samples (148; 25%). The most predominant pathogens isolated from blood, urine and stool were Staphylococcus aureus (22/70; 31%), Escherichia coli (153/356; 43%) and Vibrio parahaemolyticus (5/19; 26.3%), respectively. In CSF samples, Streptococcus pneumoniae was the most frequent pathogen detected (80/148; 54.1%). New bacterial species such as Pastuerella pneumotropica, Klebsiella oxytoca, Vibrio parahaemolyticus, and Halfnia alvei were also identified with the aid of Analytical Profile Index (API) kits that were introduced as part of this implementation. Streptococcus pneumoniae and Neisseria meningitidis detections in CSF were highest during the hot dry season. Antimicrobial susceptibility test revealed high rate of S. aureus, K. pneumoniae and E. coli resistance to gentamicin (35-55%). In urine, E. coli was highly resistant to ciprofloxacin (39.2%) and ampicillin (34%).
CONCLUSION: Detection of epidemic-prone pathogens can be greatly improved if laboratory capacity is strengthened. In-country partner organizations are encouraged to support this move to ensure accurate diagnosis of diseases and correct antimicrobial testing.

Entities:  

Keywords:  Detection; Non-governmental organization; Pathogens; Public health laboratories

Mesh:

Substances:

Year:  2021        PMID: 33765944      PMCID: PMC7993523          DOI: 10.1186/s12879-021-05999-8

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  33 in total

1.  Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing.

Authors:  Isabelle Parent du Châtelet; Yves Traore; Bradford D Gessner; Aude Antignac; B Naccro; Berthe-Marie Njanpop-Lafourcade; Macaire S Ouedraogo; Sylvestre R Tiendrebeogo; Emmanuelle Varon; Muhammed K Taha
Journal:  Clin Infect Dis       Date:  2004-12-08       Impact factor: 9.079

2.  Susceptibility of community Gram-negative urinary tract isolates to mecillinam and other oral agents.

Authors:  T Mazzulli; M Skulnick; G Small; W Marshall; D J Hoban; G G Zhanel; S Finn; D E Low
Journal:  Can J Infect Dis       Date:  2001-09

3.  The challenge of antibiotic resistance.

Authors:  S B Levy
Journal:  Sci Am       Date:  1998-03       Impact factor: 2.142

Review 4.  Emerging technologies for the clinical microbiology laboratory.

Authors:  Blake W Buchan; Nathan A Ledeboer
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

Review 5.  Urinary tract infections: epidemiology, mechanisms of infection and treatment options.

Authors:  Ana L Flores-Mireles; Jennifer N Walker; Michael Caparon; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2015-04-08       Impact factor: 60.633

6.  Recurrent Urinary Tract Infections Management in Women: A review.

Authors:  Ahmed Al-Badr; Ghadeer Al-Shaikh
Journal:  Sultan Qaboos Univ Med J       Date:  2013-06-25

7.  Trends in aminoglycoside use and gentamicin-resistant gram-negative clinical isolates in US academic medical centers: implications for antimicrobial stewardship.

Authors:  Mera Ababneh; Spencer Harpe; Michael Oinonen; Ron E Polk
Journal:  Infect Control Hosp Epidemiol       Date:  2012-04-19       Impact factor: 3.254

8.  Urinary tract infection in a rural community of Nigeria.

Authors:  Bankole Henry Oladeinde; Richard Omoregie; Mitsan Olley; Joshua A Anunibe
Journal:  N Am J Med Sci       Date:  2011-02

9.  Trends in paediatric bloodstream infections at a South African referral hospital.

Authors:  Angela Dramowski; Mark F Cotton; Helena Rabie; Andrew Whitelaw
Journal:  BMC Pediatr       Date:  2015-04-02       Impact factor: 2.125

10.  Editorial: Biological Engagement Programs: Reducing Threats and Strengthening Global Health Security Through Scientific Collaboration.

Authors:  Jeanne M Fair
Journal:  Front Public Health       Date:  2017-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.